Good morning :)
$
₹
Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

ZBH

NYSE
Asset Logo

Zimmer Biomet Holdings Inc

ZBH

NYSE
$98.480.32% (-0.32)
$
₹
$98.480.32% (-0.32)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $18.1B the stock is ranked 664

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

23.02
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.37
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$4.12
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.57
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

9.48%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 28 analysts reports

Buy
9 analysts
Hold
19 analysts
Sell
0 analyst

Price Upside

+8.47%

Earnings Growth

+4.08%

Rev. Growth

+4.43%

See Detailed Forecast

Company Profile

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
37.36
37.36
1Y Return
18.86%
18.86%
Buy Reco %
85.71
85.71
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.71
38.71
1Y Return
3.48%
3.48%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
51.76
51.76
1Y Return
17.95%
17.95%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.85
22.85
1Y Return
1.27%
1.27%
Buy Reco %
65.51
65.51
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
30.83
30.83
1Y Return
19.81%
19.81%
Buy Reco %
79.31
79.31
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 8.47% growth, versus a trailing 3-year CAGR of -1.56%.

2026
Current$98.56Baseline
Analyst Target - 1 year
Target$106.9+8.47%

All values in $

202220232024202520262027$94.94$108.96$122.98Target+8.47%
2026
Current$98.56Baseline
Analyst Target - 1 year
Target$106.9+8.47%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 4.43% growth, versus a trailing 3-year CAGR of 5.85%.

2025
Current$8.23Baseline
Forecast for Dec 2026
High$8.62+4.74%
Average$8.59+4.43%
Low$8.54+3.86%

All values in $ Billion

2021202220232024202520266.826.937.397.678.23Low+3.86%Average+4.43%High+4.74%
2025
Current$8.23Baseline
Forecast for Dec 2026
High$8.62+4.74%
Average$8.59+4.43%
Low$8.54+3.86%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 4.08% growth, versus a trailing 3-year CAGR of 5.97%.

2025
Current$8.2Baseline
Forecast for Dec 2026
High$8.57+4.51%
Average$8.53+4.08%
Low$8.49+3.54%

All values in $

2021202220232024202520267.376.897.5688.2Low+3.54%Average+4.08%High+4.51%
2025
Current$8.2Baseline
Forecast for Dec 2026
High$8.57+4.51%
Average$8.53+4.08%
Low$8.49+3.54%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

2
0.2
2.2
0.1
2
0.2
2.1
0.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue1.881.941.822.021.902.0722.242.082.17
Net Income0.170.240.240.230.180.150.230.130.230.19
Net Profit Margin9.12%12.50%13.65%11.83%9.53%7.35%11.53%6.21%11.41%9.10%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Zimmer Biomet Holdings Inc 23.021.370.57
Abbott Laboratories37.363.501.89
Danaher Corporation38.712.951.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare ZBH with any stock or ETF
Compare ZBH with any stock or ETF
Comparing from
ZBH
ABT
DHR
Loading...

Frequently asked questions

  1. Zimmer Biomet Holdings Inc (ZBH) share price today is $98.48 as of October 24, 2026 at 1:29 AM IST. The stock touched a day high of $99.30 and a day low of $97.54.

  2. Zimmer Biomet Holdings Inc stock trades on NYSE under the ticker symbol ZBH.

  3. Zimmer Biomet Holdings Inc's market capitalization is $18.09B as of October 24, 2026 at 1:29 AM IST.

  4. Zimmer Biomet Holdings Inc's price-to-earnings (P/E) ratio is 23.02 as of October 23, 2026.

  5. Zimmer Biomet Holdings Inc's price-to-book (P/B) ratio is 1.37 as of October 23, 2026.

  6. Yes, Zimmer Biomet Holdings Inc pays a dividend, with a current dividend yield of 1%.

  7. Yes, You can buy Zimmer Biomet Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Zimmer Biomet Holdings Inc shares in three steps: 1. Search Zimmer Biomet Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Zimmer Biomet Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Zimmer Biomet Holdings Inc (ZBH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1015 shares at the current price of $98.48.

Loading...